What is ASO Worldwide?
Founded in 1986, ASO Worldwide, also recognized as the ASO Group or ASO Corporation, has evolved into one of the world's largest suppliers of specialized wound care products. The company maintains a diverse portfolio that spans adhesive bandages, nasal dilators, and advanced dermatological treatments such as wart and corn removers. By leveraging decades of manufacturing expertise, ASO Worldwide has positioned itself as a critical partner for healthcare providers and retail consumers alike. Their operational model emphasizes high-volume production efficiency and stringent quality control, which has allowed them to maintain a leading market share in the competitive medical supplies industry.
How much funding has ASO Worldwide raised?
ASO Worldwide has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in ASO Worldwide
PPP
Public-Private Partnership
What's next for ASO Worldwide?
With the recent injection of capital, ASO Worldwide is well-positioned to navigate the complexities of the current enterprise-level manufacturing landscape. The strategic allocation of these funds will likely focus on optimizing production throughput and enhancing the technological integration of their Sarasota facilities. As the company continues to scale, the focus will remain on maintaining its status as a premier global supplier while exploring new product verticals within the broader wound care and consumer health markets. This financial milestone provides the necessary liquidity to pursue long-term operational efficiencies and sustain competitive advantages in an increasingly demanding global supply chain environment.
See full ASO Worldwide company page
